MRI-Guided Neoadjuvant Chemotherapy Could be Used in HR-/HER2+ Breast Cancer
MRI-guided treatment could be used to optimize the duration of neoadjuvant chemotherapy in hormone receptor-negative/HER2-positive breast cancer.
Noord Holland Netherlands Cancer Institute Department Of Medical Oncology Medical Oncology Mri Guided Neoadjuvant Chemotherapy Hr Her2 Breast Cancer
Source: onclive.com